Buy Thymosin Alpha 1 (10mg)

Overview

Thymosin Alpha 1 (Tα1) is a 28-amino-acid peptide derived from the thymus gland, celebrated for its potent immune-modulating properties. Widely studied for its antiviral, antibacterial, antifungal, and antitumor actions, Tα1 is clinically approved in several countries, especially for managing chronic hepatitis B and C and as an adjunctive therapy in immune-compromised conditions.

Benefits

• Immune Regulation: Supports balanced immune responses.
• Antiviral Action: Effective against viral infections, including hepatitis and respiratory viruses.
• Antifungal & Antibacterial: Enhances pathogen clearance via dendritic cell action.
• Antitumor Effects: Boosts immune surveillance and complements cancer therapies.
• Adjuvant Therapy: Supports treatment for cancers such as breast, liver, lung, colon, and melanoma.

Mechanism of Action

1. Enhances T-Cell Function: Promotes maturation and activity of T-cells.
2. Boosts Dendritic Cell Activity: Improves antigen presentation and pathogen recognition.
3. Increases CD4/CD8 Ratios: Strengthens adaptive immune responses.
4. Regulates Cytokines & Chemokines: Balances inflammatory and immune signals.

Research Highlights

1. Antiviral Properties
   1. Enhances natural killer (NK) cells and cytotoxic T-cell activity.
   2. Upregulates interferon-alpha (IFN-α) and other cytokines critical for antiviral defenses.
   3. Clinical Impact:
      1. Demonstrated reduced HBV DNA levels in chronic hepatitis B patients (ClinicalTrials.gov Identifier: NCT00006292).
      2. Promising adjunctive therapy for COVID-19, mitigating cytokine storms and severe complications.
2. Antibacterial & Antifungal Properties
   1. Improves macrophage activation and dendritic cell maturation.
   2. Effective against multidrug-resistant infections and opportunistic pathogens.
   3. Key Findings:
      1. Reduces bacterial burden in sepsis models.
      2. Demonstrates in vitro efficacy against Candida albicans.
3. Antitumor Properties
   1. Restores immune surveillance mechanisms impaired by tumors.
   2. Enhances efficacy of chemotherapy and immune checkpoint inhibitors.
   3. Clinical Evidence:
      1. Improved survival rates in non-small cell lung cancer when combined with chemotherapy (doi:10.1007/s00432-020-03422-5).
      2. Promotes tumor regression in melanoma through T-cell activation.
4. Immune Regulation
   1. Balances innate and adaptive immunity while reducing excessive inflammation.
   2. Restores homeostasis in immune suppression or dysregulation.
   3. Mechanisms:
      1. Activates TLR pathways and regulates NF-κB signaling for controlled cytokine production.